Compare · CAI vs CNC
CAI vs CNC
Side-by-side comparison of Caris Life Sciences Inc. (CAI) and Centene Corporation (CNC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAI and CNC operate in Medical Specialities (Health Care), so they compete in similar markets.
- CNC is the larger of the two at $45.09B, about 46.4x CAI ($971.9M).
- CAI has been more active in the news (10 items in the past 4 weeks vs 8 for CNC).
- CNC has more recent analyst coverage (25 ratings vs 14 for CAI).
- Company
- Caris Life Sciences Inc.
- Centene Corporation
- Price
- $20.21+2.12%
- $41.83+1.76%
- Market cap
- $971.9M
- $45.09B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NYSE
- IPO
- 2025
- News (4w)
- 10
- 8
- Recent ratings
- 14
- 25
Caris Life Sciences Inc.
CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. The company leases, re-leases, and disposes equipment; and contracts for the repair, repositioning, and storage of equipment. It leases its container equipment to lessees under long-term, short-term, and finance leases. The company also sells containers; and manages equipment for to third-party investors, as well as sells used containers. As of December 31, 2020, it had a container fleet comprised 1,798,520 cost equivalent units. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California.
Centene Corporation
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; and vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Latest CAI
- Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
- SEC Form DEFA14A filed by Caris Life Sciences Inc.
- SEC Form DEF 14A filed by Caris Life Sciences Inc.
- Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026
- Caris Precision Oncology Alliance Welcomes UCSF Helen Diller Family Comprehensive Cancer Center
- Caris Life Sciences Right-In-Time Clinical Trial Solution Expands Access to Precision Oncology Trials for Historically Underserved Cancer Patients
- Jefferies initiated coverage on Caris Life Sciences with a new price target
- Piper Sandler initiated coverage on Caris Life Sciences with a new price target
- Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients
- Amendment: SEC Form SCHEDULE 13G/A filed by Caris Life Sciences Inc.
Latest CNC
- Centene Foundation Reports $34.9 Million Invested in Community Health, Education and Social Services in 2025
- Superior HealthPlan Employees Contributed More Than 3,000 Volunteer Hours Across Texas Communities in 2025
- Los Angeles Residents to Gain Faster Access to New Affordable Housing through Health Net's $10 Million Investment in "Guarantee Fund"
- Home State Health and Centene Foundation Launch Medical Respite Program in St. Louis
- SEC Form 4 filed by Mcnally Tanya M
- CENTENE CORPORATION TO HOST 2026 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL
- Sunshine Health Delivers Career Pathways for Floridians and Advances Healthcare Workforce
- Centene Announces New Executive Leadership Structure
- St. Vincent Behavioral Health Campus Expands Housing & Health Care for LA with $6M Health Net Investment
- Carolina Complete Health and WellCare of North Carolina Combine to Form Provider-Led Managed Care Organization